A sequel to one of the most important eye studies is now taking place. It is called the AREDS 2 (Age-Related Eye Disease Study 2) trial and it is being conducted by the National Eye Institute (NEI). The original AREDS study showed that taking certain antioxidants was beneficial in reducing vision loss from macular degeneration. The tested nutrients were vitamins C, E, beta-carotene, zinc, and copper.
THESE INGREDIENTS ARE ALREADY PRESENT IN VISIVITE NON-SMOKER FORMULATIONS (SMOKER VERSIONS REMOVE BETA-CAROTENE)
This second AREDS study will explore the effects of these additional ingredients: 10 mg. lutein, 2 mg. zeaxanthin, 350 mg. DHA (docosahexaenoic acid), and 650 mg. EPA (eicosapentaenoic acid).
Why are these ingredients being added?
Lutein and Zeaxanthin are macular pigments and are believed to protect the macula from damage caused by continued exposure to light. They act as “sunscreens” to filter out UV light and fight oxidative damage, and both are found in healthy retinas. Other benefits of Lutein and Zeaxanthin include a lower rate of cataracts, cancer prevention, less cognitive decline, and cardiovascular benefits.
EPA and DHA are Omega-3 fatty acids (“good fats”) present in cold-water fish. They are thought to decrease the damaging effects of light exposure, stress, and inflammation. DHA is present in the photoreceptors of the retina. These photoreceptors convert light energy into the electrical signals that our brains interpret as images. EPA is involved in certain processes that occur in eye tissues.
A study published in the June 2008 issue of Archives of Ophthalmology has proven that EPA and DHA actually PREVENT macular degeneration in healthy eyes.
Vitamin Science is proud to be the first and only company to offer an eye supplement based upon the latest National Eye Institute Study. It is called VisiVite Premier Ocular Formula No. 2.
Goepp, MD, Julius G.. "Protecting Our Eyes Against Time-Induced Damage." Life Extension June 2008: 43-49.
Folk, MD, James C.. "New Studies Underway: AREDS 2." [Weblog Age-Related Macular Degeneration] 22 Jan 2007. MedRounds Publications. 05 Jun 2008 <http://www.medrounds.org/amd/2007/01/new-studies-underway-areds-2.html>.